The glucose-reducing drug empagliflozin (Jardiance) now has approval from the FDA after the drug maker corrected manufacturing problems that caused the agency to say “no” in March…. The sodium glucose cotransporter 2 (SGLT2) is indicated for improving glycemic control in adults with type 2 diabetes in conjunction with diet and …

Elevated blood pressure is associated with an increased risk of renal damage in patients with type 2 diabetes, especially if they have poor glycemic control…. 

A peptide called caerulein can convert existing cells in the pancreas into insulin-generating beta cells….

This week I got to see exactly how easy it is for our patients to add extra calories and sugar to their daily routine. It seems that Labor Day is no longer a holiday worthy of a special section in the grocery store for holiday food. On August 14, grocery …

This week in Part 4 of our Homerun Slides series, Dr. Schwartz finishes up by looking at the treatments for LADA, MODY, type 1 and type 2 diabetes, and makes a case for using medications that replace or enhance incretin availability. He even delves into the idea of treating pre-diabetes …

Diabetes is a huge and growing problem, and the costs to society are high and escalating. In Southeast Asia, half of people with diabetes are undiagnosed. The Top 5 countries for prevalence in this region are: Mauritius, India, Sri Lanka, Bangladesh, and Bhutan. To find out more, follow the link. …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP   Diabetic control ‘defines the extent to which the metabolism in the person with diabetes differs from that in the person without diabetes. Measurement usually focuses on blood glucose: ‘good ‘ control implies maintenance of near-normal blood glucose concentrations throughout the day. …

New Basal Insulin Approved. See the Product of the Week. New Test Approved to Diagnose Type 1 Diabetes. See this week’s Facts.

The Risk Calculator  Predicting Risk for Developing Diabetes. Blood glucose levels measured in hospitalized patients during acute illness can be used to predict the risk of developing type 2 diabetes in the following three years. The Risk Calculator

Basaglar (insulin glargine injection) by Lilly and Boehringer  The FDA has granted tentative approval for Basaglar (insulin glargine injection), a basal insulin. Basaglar is Eli Lilly and Co. and Boehringer Ingelheim"s basal insulin. Basaglar has the same amino acid sequence as the currently marketed insulin glargine product. While the FDA …